à"Tumornecrosis factor-a (TNF-a) has been shown to have somnogenic properties. Plasma levels of this cytokine have been found to increase significantly during dialysis with a bioincompatible (cuprophane) membrane in patients with postdialysis fatigue (PDF). We conducted a crossover study with random assignment to ascertain whether a biocompatible membrane might attenuate the increase of TNF-a and severity of PDF. Sixteen patients on maintenance hemodialysis underwent dialysis with either cuprophane (n = 8) or polymethylmethacrylate (PMMA; n -8) membranes for 1 week and then switched to the opposite membrane during the second week. Predialysis and postdialysis measurements of plasma TNF-a levels were performed during the first and last dialysis treatments of each week. A fatigue score was determined from the sum of duration of fatigue and sleep within 6 hours of the completion of dialysis. TNF-a levels increased by an average of 18.3% during dialysis with cuprophane membranes but only 2.4% with PMMAmembranes (P = 0.04). Despite this, fatigue scores remained unaltered (~4 of 6). Hence, the biocompatible membrane, PMMA,failed to alleviate PDF. This suggests that dialytic stimulation of TNF-a plays no substantial role in the pathogenesis of PDF. ©1998 by the National Kidney Foundation, Inc.
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P OSTDIALYSIS FATIGUE (PDF) of varying severity routinely affects a substantial portion of the hemodialysis population.1 It further impairs the quality of life for patients whose lives are already compromised by chronic illness. Moreover, PDF is sometimes offered as the reason for patients' reluctance to conform to their optimal dialysis prescriptions, particularly when they involve additional dialysis days. The cause of this effect of hemodialysis has been incompletely addressed in the renal literature. It is well-known to anyone involved in the day-to-day management of dialysis patients that excessive ultrafiltration can result in the acute onset of dramatic symptoms, including profound weakness, lightheadedness, and.muscle cramps. These effects are often associated with hypotension and resolve with the administration of fluid. The cause and managementof chronic and recurrent interdialytic fatigue are not as well defined. Rapid osmolar flux is generally believed, although not proven, to be the basis for the development of many intradialytic and interdialytic symptoms, including PDF.2-3 Dinarello4 has proposed that proinflammatory cytokines, eg, interleukin-l p and tumor necrosis factor-a (TNF-a), generated by the exposure of blood to certain hemodialysis membranes, may be involved in the pathogenesis of dialysis "washout." There is a plethora of evidence showing that these cytokines induce slow-wave sleep in various mammalianspecies. 5 In a previous study performed on patients dialyzed on bioincompatible membranes, we showed statistically greater intradialytic increases in TNF-a levels in patients with PDF than in those without PDF.6This observation suggests, but does not verify, that TNF-a and perhaps related cytokines are involved in the induction of PDF. It has been shown that biocompatible membranes do not stimulate the release of TNF-a and other cytokines to the extent that bioincompatible membranes do.7"10 If sornnogenic cytokines are indeed responsible for the production of a feeling of exhaustion after dialysis, then use of a biocompatible membraneshould alleviate this problem. Using two different types of membranes and TNF-aas a marker of their biocompatibility, we performed a prospective crossover study to evaluate the potential role for this particular type of bloodmembraneinteraction in the pathogenesis of PDF.
MATERIALS AND METHODS

Patient Selection
Weidentified 25 outpatients receiving maintenance hemodialysis treatments with cuprophane membranes during day-time shifts who were previously defined to have chronic recurrent PDF by a combination of questionnaire and log data.6 Briefly, the patients were screened initially and retrospectively by using a fatigue index questionnaire (one third of the sum of the intensity, duration, and frequency of PDF each rated from 1 to 5). Those with an index greater than 4 were assigned to a PDF group, whereas those with an index less than 2 were assigned to a non-PDF group. Wevalidated the assignment by having each patient prospectively record, over 1 week, all time intervals during which they felt fatigued as well as required bedrest or sleep. Whereas non-PDF patients experienced little or no fatigue after dialysis and did not record periods of rest or sleep after dialysis sessions, PDF patients all described severe fatigue and requirement ofat least 2 hours of rest or sleep within 6 hours of dialysis treatments. Twenty-one of the patients affected by PDF agreed to participate in the current study.
Protocol
A crossover study was performed over a 2-week period. During the first week, half of the patients were randomly assigned to dialyze either on a 1.2-m2 surface area cuprophane membrane (Capillary Flow Dialyzer; Baxter Healthcare Corp. Deerfield, IL) or on a 1.25-m2 low-flux polymethylmethacrylate (PMMA) membrane, (Toray, Tokyo, Japan). During the second week, patients were switched to the opposite membranes. Patients were blinded with respect to the type of membrane used during all dialysis treatments throughout the study. Each patient was dialyzed thrice weekly on a Baxter SPS 550 machine (Baxter Healthcare Corp). Dialysate was delivered at 500 mL and had the following composition:
sodium, 138 mEq/L; calcium, 3.5 mEq/L; magnesium, 1.3 mEq/L; and bicarbonate, 36 mEq/L. Ultrafiltration was performed at a constant rate with the patient's estimated dry weight as the ultrafiltration goal. Blood samples were drawn pre-and postdialysis during the first and last treatments of each week for subsequent TNF-aanalysis. Levels of PDF were determined by analysis of 6-hour logs of sleep and perception/of fatigue recorded by patients after each of these dialysis treatments. At the completion of the study, the patients submitted their log sheets to one of the investigators.
Analytic Methods
Blood samples were centrifuged, separated into cryotubes, and frozen at -20°C within 60 minutes of blood sample collection for subsequent analysis. Assays for TNF-a were performed in duplicate by using commercially available enzyme-linked immunosorbent assay kits (Quantikine HS, R&D Systems, Minneapolis, MN).
Fatigue scores were calculated as the sum of the hours of sleep and the hours of fatigue experienced by patients for up to 6 hours after each dialysis treatment. Pearson correlation was used to determine the relationship between TNF-a levels and fatigue scores. Initial comparison of fatigue scores was assessed by the Wilcoxon signed-rank test. Comparison of TNF-a levels and fatigue scores between membranes was performed by using analysis of variance with repeated measures. The interaction of fatigue and TNF-a levels between membranes was also evaluated by using repeated measures analysis with interaction. Analyses were performed on a personal computer using CRUNCH 4 (Crunch Corp. Oakland, CA) and SAS 6.07 (SAS Institute Inc, Gary, NC). Data are presented as mean ± standard error of the mean.
RESULTS
Five patients
were not included in the data analysis because they were individuals who destabilized medically (n = 2) or submitted incomplete log sheets (n = 3). The remaining 16 patients had a mean age of 61 ± 3 years and included 9 men and 7 women. Causes of renal failure included diabetes mellitus (n = 7), hypertension (n = 3), chronic glomerulonephritis (n = 4), polycystic kidney disease (n = 1), and analgesic abuse (n = 1). On questioning at the completion of the study, these patients denied knowledge of which type of dialyzer they had been treated with during either phase of the study.
There were no significant differences between membranes in the percent reductions (pre-to postdialysis) of osmolality (6.4 v 6.3), body weight (3.2 v 3.3), and systolic blood pressure (9.0 v 9.0). TNF-a results, expressed as percent change from baseline, and fatigue scores are shown in Fig 1. The baseline levels of TNF-a were between 10.4 and 11.9 pg/mL and increased by nearly 20% in patients when dialyzed with cuprophane membranes. Despite significant suppression of the mtradialytic augmentation of TNF-a levels by dialysis with PMMA membranes (P = 0.04), fatigue scores remained high and essentially unaltered (P = 0.50). There was no statistically significant correlation between TNF-a level and fatigue score for either cuprophane or PMMAmembranes (r = 0.24 and r = 0.03, respectively).
To minimize the possibility of carryover effects between dialyzers, we compared TNF-a and fatigue levels obtained from the final dialysis treatments of each week, ie, a week apart. The results of this analysis amplified the above findings with suppression of intradialytic augmentation of TNF-a achieving a P of 0.02 and fatigue scores remaining unchanged (P = 0.64).
DISCUSSION
The small sample of subjects available to us for this study dictated the short time frame for its execution; we were concerned about potential dropout of already small numbers of these chroni- cally i l l individuals because of acute disease conditions. The crossover design, however, enabled us to compensate statistically for the small numbers of patients. The potential influence of one membraneon the subsequent biological behavior of patients while on the other membrane (ie, carryover effect) must be acknowledged in a short-term study such as this. We believe, however, that sufficient time was allowed to elapse between data collection on different membranes to provide for washout of short-lived dialysisinduced changes in TNF-a and other cytokines1 1 as well as for fatigue. ' The sensation of fatigue, a major outcome variable in this study, remains subjective and, hence, difficult to quantify precisely. The lack of an objective scale by which the degree of fatigue was determined in this investigation may cast doubt on its conclusions. In this study, however, we instructed the patients to simply record the presence or absence of fatigue for 6 hours after dialysis. Furthermore, as discussed more completely in a previous publication,1 it may be argued that patients' own perceptions of fatigue mayultimately be more important than any objective measure of this symptom.
Hemodialysis-induced fatigue results from either blood-membrane interactions or rapid flux of solutes and water across the dialysis membrane. In a previous study,6 we found a significantly greater increase in levels ofTNF-a during dialysis with cuprophane membranes in patients with PDF compared with patients not suffering from PDF. Interleukin-lp level was also evaluated but was found to increase less impressively; therefore, we concentrated our efforts in the current study on TNF-a. As in some,7"10 but not all, previous studies (as reviewed by Pereira1 1), we found that the biocompatible membrane, PMMA,was not associated with an increase in TNF-a levels. The demonstration of similar levels of fatigue after all dialysis treatments in the current investigation casts doubt on the concept that this monokine is involved in the genesis of PDF. It leaves open the possibility, however, that other blood-membrane interactions shared by these membranes are involved. From a practical point of view, our study negates a role for the biocompatible PMMAmembranein the amelioration of PDF.
The conventional wisdom that chronic intraand interdialytic somatic effects, including PDF, are related to rapid osmotic flux remains intriguing but unsubstantiated.
In previous observational studies,1-6 we found no differences in intradialytic declines in plasma osmolality between groups of patients with and without chronic recurrent PDF. Of course, differential sensitivity to the effects of rapid changes in extracellular fluid osmolality or differences in rates of idiogenic osmole production by brain cells12 could be of paramount importance. Prior experimental studies showing that maintenance of plasma osmolality lessens dialysis-associated symptoms suggest a role for rapid molecular flux in the induction of PDF.2-3 Conclusions from these observations, however, must be tempered by a recent study by Sang et al13 that showed worsening of postdialysis levels of fatigue in patients whose intradialytic serum sodium concentrations were increased by sodium ramping.
In conclusion, the etiologic factor(s) responsible for the development of chronic recurrent PDF has not been definitively ascertained. Until the pathogenesis of this commoncondition is unraveled, and a strategy for treatment developed, many patients with end-stage renal disease will continue to view postdialysis malaise as an unpleasant but inevitable consequence of the hemodialysis process.
